141 related articles for article (PubMed ID: 9808561)
1. Association between ligand-induced conformational changes of integrin IIbbeta3 and IIbbeta3-mediated intracellular Ca2+ signaling.
Honda S; Tomiyama Y; Aoki T; Shiraga M; Kurata Y; Seki J; Matsuzawa Y
Blood; 1998 Nov; 92(10):3675-83. PubMed ID: 9808561
[TBL] [Abstract][Full Text] [Related]
2. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
3. RGD-ligand mimetic antagonists of integrin alphaIIbbeta3 paradoxically enhance GPVI-induced human platelet activation.
Jones ML; Harper MT; Aitken EW; Williams CM; Poole AW
J Thromb Haemost; 2010 Mar; 8(3):567-76. PubMed ID: 20002543
[TBL] [Abstract][Full Text] [Related]
4. Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54.
Naimushin YA; Mazurov AV
Biochemistry (Mosc); 2005 Jul; 70(7):782-9. PubMed ID: 16097942
[TBL] [Abstract][Full Text] [Related]
5. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
Schwarz M; Meade G; Stoll P; Ylanne J; Bassler N; Chen YC; Hagemeyer CE; Ahrens I; Moran N; Kenny D; Fitzgerald D; Bode C; Peter K
Circ Res; 2006 Jul; 99(1):25-33. PubMed ID: 16778135
[TBL] [Abstract][Full Text] [Related]
6. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.
Naimushin YA; Mazurov AV
Platelets; 2004 Nov; 15(7):419-25. PubMed ID: 15745313
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Na+/Ca2+ exchanger in inside-out signaling through the platelet integrin IIbbeta3.
Shiraga M; Tomiyama Y; Honda S; Suzuki H; Kosugi S; Tadokoro S; Kanakura Y; Tanoue K; Kurata Y; Matsuzawa Y
Blood; 1998 Nov; 92(10):3710-20. PubMed ID: 9808565
[TBL] [Abstract][Full Text] [Related]
8. Synergistic outside-in regulation of platelet activation by GPIIb/IIIa ligand-induced conformation and oligomerization.
Wang XF; Liu F; Morris SA; Carroll RC
Thromb Res; 2001 Nov; 104(4):239-47. PubMed ID: 11728525
[TBL] [Abstract][Full Text] [Related]
9. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of a ligand induced binding site (LIBS) by GPIIb-IIIa ligand recognition peptides and parenteral antagonists.
Jennings LK; Haga JH; Slack SM
Thromb Haemost; 2000 Dec; 84(6):1095-102. PubMed ID: 11154119
[TBL] [Abstract][Full Text] [Related]
11. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
Huang TF; Chang CH; Ho PL; Chung CH
Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
[TBL] [Abstract][Full Text] [Related]
12. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses.
Matsumoto Y; Marukawa K; Okumura H; Adachi T; Tani T; Kimura Y
Thromb Res; 1999 Jul; 95(1):19-29. PubMed ID: 10403683
[TBL] [Abstract][Full Text] [Related]
14. Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in vivo.
Murphy NP; Pratico D; Fitzgerald DJ
J Pharmacol Exp Ther; 1998 Aug; 286(2):945-51. PubMed ID: 9694954
[TBL] [Abstract][Full Text] [Related]
15. MK-383 (tirofiban) induces a GPIIb/IIIa receptor conformation which differs from the resting and activated receptor.
Barlage S; Wimmer A; Pfeiffer A; Rothe G; Schmitz G
Platelets; 2002 May; 13(3):133-40. PubMed ID: 12180495
[TBL] [Abstract][Full Text] [Related]
16. A sequence within the cytoplasmic tail of GpIIb independently activates platelet aggregation and thromboxane synthesis.
Stephens G; O'Luanaigh N; Reilly D; Harriott P; Walker B; Fitzgerald D; Moran N
J Biol Chem; 1998 Aug; 273(32):20317-22. PubMed ID: 9685382
[TBL] [Abstract][Full Text] [Related]
17. Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin.
Bougie DW; Rasmussen M; Zhu J; Aster RH
Blood; 2012 Jun; 119(26):6317-25. PubMed ID: 22490676
[TBL] [Abstract][Full Text] [Related]
18. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.
Mondoro TH; Wall CD; White MM; Jennings LK
Blood; 1996 Nov; 88(10):3824-30. PubMed ID: 8916946
[TBL] [Abstract][Full Text] [Related]
19. Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists.
Dickfeld T; Ruf A; Pogatsa-Murray G; Müller I; Engelmann B; Taubitz W; Fischer J; Meier O; Gawaz M
Thromb Res; 2001 Jan; 101(2):53-64. PubMed ID: 11342206
[TBL] [Abstract][Full Text] [Related]
20. Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions.
Leclerc JR
Crit Care Med; 2002 May; 30(5 Suppl):S332-40. PubMed ID: 12004256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]